Selective Extracellular Signal-Regulated Kinase 1/2 (ERK1/2) Inhibition by the SCH772984 Compound Attenuates In Vitro and In Vivo Inflammatory Responses and Prolongs Survival in Murine Sepsis Models

被引:15
|
作者
Kopczynski, Michal [1 ]
Rumienczyk, Izabela [1 ]
Kulecka, Maria [1 ,2 ]
Statkiewicz, Malgorzata [1 ]
Pysniak, Kazimiera [1 ]
Sandowska-Markiewicz, Zuzanna [1 ]
Wojcik-Trechcinska, Urszula [1 ]
Goryca, Krzysztof [3 ]
Pyziak, Karolina [4 ]
Majewska, Eliza [4 ]
Masiejczyk, Magdalena [4 ]
Wojcik-Jaszczynska, Katarzyna [4 ]
Rzymski, Tomasz [4 ]
Bomsztyk, Karol [5 ]
Ostrowski, Jerzy [1 ,2 ]
Mikula, Michal [1 ]
机构
[1] Maria Sklodowska Curie Natl Res Inst Oncol, Dept Genet, PL-02781 Warsaw, Poland
[2] Ctr Postgrad Med Educ, Dept Gastroenterol Hepatol & Clin Oncol, PL-01813 Warsaw, Poland
[3] Univ Warsaw, Ctr New Technol, Genom Core Facil, PL-02097 Warsaw, Poland
[4] Ryvu Therapeut SA, Biol R&D, PL-30394 Krakow, Poland
[5] Univ Washington, UW Med South Lake Union, Seattle, WA 98109 USA
基金
美国国家卫生研究院;
关键词
sepsis; drugs repurposing; ERK1/2; SCH772984; cecal ligation and puncture; READ ALIGNMENT; CECAL LIGATION; PATHWAY; TRANSCRIPTION; DEFINITIONS; DYSFUNCTION; DISRUPTION; DISCOVERY; ROLES; EGFR;
D O I
10.3390/ijms221910204
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Sepsis is the leading cause of death in intensive care units worldwide. Current treatments of sepsis are largely supportive and clinical trials using specific pharmacotherapy for sepsis have failed to improve outcomes. Here, we used the lipopolysaccharide (LPS)-stimulated mouse RAW264.7 cell line and AlphaLisa assay for TNFa as a readout to perform a supervised drug repurposing screen for sepsis treatment with compounds targeting epigenetic enzymes, including kinases. We identified the SCH772984 compound, an extracellular signal-regulated kinase (ERK) 1/2 inhibitor, as an effective blocker of TNFa production in vitro. RNA-Seq of the SCH772984-treated RAW264.7 cells at 1, 4, and 24 h time points of LPS challenge followed by functional annotation of differentially expressed genes highlighted the suppression of cellular pathways related to the immune system. SCH772984 treatment improved survival in the LPS-induced lethal endotoxemia and cecal ligation and puncture (CLP) mouse models of sepsis, and reduced plasma levels of Ccl2/Mcp1. Functional analyses of RNA-seq datasets for kidney, lung, liver, and heart tissues from SCH772984-treated animals collected at 6 h and 12 h post-CLP revealed a significant downregulation of pathways related to the immune response and platelets activation but upregulation of the extracellular matrix organization and retinoic acid signaling pathways. Thus, this study defined transcriptome signatures of SCH772984 action in vitro and in vivo, an agent that has the potential to improve sepsis outcome.
引用
收藏
页数:17
相关论文
共 50 条
  • [21] Effects of hypothalamic neuropeptides on extracellular signal-regulated kinase (ERK1 and ERK2) cascade in human tumoral pituitary cells
    Lania, A
    Filopanti, M
    Corbetta, S
    Losa, M
    Ballaré, E
    Beck-Peccoz, P
    Spada, A
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (04): : 1692 - 1696
  • [22] Mechanisms of parathyroid hormone (PTH) inhibition of extracellular signal-regulated kinases (ERK1/2) in chondrocytic cells.
    Lai, LP
    Mitchell, J
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S199 - S199
  • [23] Multiple Division Cycles and Long-Term Survival of Hepatocytes Are Distinctly Regulated by Extracellular Signal-Regulated Kinases ERK1 and ERK2
    Fremin, Christophe
    Bessard, Anne
    Ezan, Frederic
    Gailhouste, Luc
    Regeard, Morgane
    Le Seyec, Jacques
    Gilot, David
    Pages, Gilles
    Pouyssegur, Jacques
    Langouet, Sophie
    Baffet, Georges
    HEPATOLOGY, 2009, 49 (03) : 930 - 939
  • [24] Extracellular S100A1 protein inhibits apoptosis in ventricular cardiomyocytes via activation of the extracellular signal-regulated protein kinase 1/2 (ERK1/2)
    Most, P
    Boerries, M
    Eicher, C
    Schweda, C
    Ehlermann, P
    Pleger, ST
    Loeffler, E
    Koch, WJ
    Katus, HA
    Schoenenberger, CA
    Remppis, A
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (48) : 48404 - 48412
  • [25] Aberrant extracellular signal-regulated kinase (ERK)1/2 signalling in suicide brain: role of ERK kinase 1 (MEK1)
    Dwivedi, Yogesh
    Rizavi, Hooriyah S.
    Zhang, Hui
    Roberts, Rosalinda C.
    Conley, Robert R.
    Pandey, Ghanshyam N.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2009, 12 (10): : 1337 - 1354
  • [26] Discovery and structure activity relationship study of novel indazole amide inhibitors for extracellular signal-regulated kinase1/2 (ERK1/2)
    Li, Lei
    Liu, Feifei
    Jin, Nan
    Tang, Shuai
    Chen, Zhuxi
    Yang, Xiaotong
    Ding, Jian
    Geng, Meiyu
    Jiang, Lei
    Huang, Min
    Cao, Jianhua
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (11) : 2600 - 2604
  • [27] Epoxyeicosatrienoic Acids (EETs) Regulate Epithelial Sodium Channel Activity by Extracellular Signal-regulated Kinase 1/2 (ERK1/2)-mediated Phosphorylation
    Pidkovka, Nataliya
    Rao, Reena
    Mei, Shaojun
    Gong, Yan
    Harris, Raymond C.
    Wang, Wen-Hui
    Capdevila, Jorge H.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2013, 288 (07) : 5223 - 5231
  • [28] Enhancement of vitamin C-induced myogenesis by inhibition of extracellular signal-regulated kinase (ERK) 1/2 pathway
    Fu, Xiajie
    Matsui, Tohru
    Funaba, Masayuki
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2022, 612 : 57 - 62
  • [29] Extracellular signal-regulated kinase 1/2 signaling promotes oligodendrocyte myelination in vitro
    Xiao, Junhua
    Ferner, Anita H.
    Wong, Agnes W.
    Denham, Mark
    Kilpatrick, Trevor J.
    Murray, Simon S.
    JOURNAL OF NEUROCHEMISTRY, 2012, 122 (06) : 1167 - 1180
  • [30] Kinase supressor of Ras-1 in neuronal survival signaling by extracellular signal-regulated kinase 1/2
    Szatmari, E. M.
    Kalita, K.
    Kharebava, G.
    Hetman, M.
    JOURNAL OF NEUROCHEMISTRY, 2007, 102 : 119 - 119